Atea Pharmaceuticals Inc. (AVIR)

Atea Pharmaceuticals Inc. (AVIR $3.46)
- $3.46 Cap: $298M
- View AVIR Profile
- View Questions on AVIR

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Atea Pharmaceuticals Inc. (AVIR $3.46)
- $3.46 Cap: $298M
- View AVIR Profile
- View Questions on AVIR

Q: Please comment whether this stock is a buy after the huge drop?

Read Answer Asked by Imtiaz on October 20, 2021

Atea Pharmaceuticals Inc. (AVIR $3.46)
- $3.46 Cap: $298M
- View AVIR Profile
- View Questions on AVIR

Q: Hi team,

What are your thoughts on Atea pharmaceuticals? Apparently they are in stage 3 trials of an oral Covid therapy drug? It has had a significant pull back off it’s highs.

Thanks,
Kerri

Read Answer Asked by KERRI on June 29, 2021